Zode et al. have reported that topical ocular phenylbutyric acid (PBA) treatment rescues mutant myocilin associated and steroid induced ocular hypertension by decreasing ER stress in the TM [33,34]. The gene discussed is MYOC; the disease is ocular hypertension.